
BRIDGEBIO PHARMA INC
BBIO · NASDAQ
Updated at 2026-10-13 14:11:10
- Today's High
- $66.07
- Today’s Low
- $64.30
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $65.35
- Previous Close
- $65.75
- Volume
- 1.77M
- Market Cap
- $12.85B
- P/E Ratio
- --
- EPS
- $-3.56
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3160 PORTER DRIVE, PALO ALTO, CA, UNITED STATES, 94304
- Country
- US
- Listing Date
- 2019-06-27
- Fiscal Year End
- December
- Shares Outstanding
- 195.86M
- CIK
- 0001743881
- Website
- bridgebio.com
BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. The company is headquartered in Palo Alto, California.
Financial Metrics
Revenue
2026-06-30
$243.67M
2026-03-31
$194.51M
2025-12-31
$154.18M
2025-09-30
$120.7M
Operating Expenses
2026-06-30
$335.7M
2026-03-31
$290.04M
2025-12-31
$324M
2025-09-30
$259.33M
Net Income
2026-06-30
-$152.21M
2026-03-31
-$164.04M
2025-12-31
-$197.23M
2025-09-30
-$182.74M
Net Profit Margin
2026-06-30
-62.46%
2026-03-31
-84.33%
2025-12-31
-127.92%
2025-09-30
-151.4%
Earnings Per Share
2026-06-30
$-0.78
2026-03-31
$-0.84
2025-12-31
$-0.93
2025-09-30
$-0.72
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$141.56M
2026-03-31
-$112.55M
2025-12-31
-$183.8M
2025-09-30
-$173.34M
Effective Tax Rate
2026-06-30
3.96%
2026-03-31
--
2025-12-31
--
2025-09-30
0.82%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $243.67M | $194.51M | $154.18M | $120.7M |
| Operating Expenses | $335.7M | $290.04M | $324M | $259.33M |
| Net Income | -$152.21M | -$164.04M | -$197.23M | -$182.74M |
| Net Profit Margin | -62.46% | -84.33% | -127.92% | -151.4% |
| Earnings Per Share | $-0.78 | $-0.84 | $-0.93 | $-0.72 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$141.56M | -$112.55M | -$183.8M | -$173.34M |
| Effective Tax Rate | 3.96% | -- | -- | 0.82% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.